BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND MYD88, Q99836, MYD88D, 4615 AND Treatment
7 results:

  • 1. Transcriptional Inflammatory Signature in Healthy Donors and Different Radiotherapy cancer Patients.
    O'Brien G; Kamuda M; Cruz-Garcia L; Polozova M; Tichy A; Markova M; Sirak I; Zahradnicek O; Widłak P; Ponge L; Polanska J; Badie C
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256152
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Zoledronic acid and thymosin α1 elicit antitumor immunity against prostate cancer by enhancing tumor inflammation and cytotoxic T cells.
    Wang S; Huang M; Chen M; Sun Z; Jiao Y; Ye G; Pan J; Ye W; Zhao J; Zhang D
    J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37295817
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tempol differential effect on prostate cancer inflammation: In vitro and in vivo evaluation.
    Rossetto I; Santos F; Kido L; Lamas C; Montico F; Cagnon V
    Prostate; 2023 Apr; 83(5):403-415. PubMed ID: 36546327
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Evaluation of G2013 (α-L-guluronic acid) efficacy on PC-3 cells through inhibiting the expression of inflammatory factors.
    Bagherian Z; Mirshafiey A; Mohsenzadegan M; Farajollahi MM
    Clin Exp Pharmacol Physiol; 2022 Feb; 49(2):254-263. PubMed ID: 34699087
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MPSSS impairs the immunosuppressive function of cancer-associated fibroblasts via the TLR4-NF-κB pathway.
    Xu Y; Ma J; Zheng Q; Wang Y; Hu M; Ma F; Qin Z; Lei N; Tao N
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30992392
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine prostate cancer Progression.
    Li Y; Xie N; Chen R; Lee AR; Lovnicki J; Morrison EA; Fazli L; Zhang Q; Musselman CA; Wang Y; Huang J; Gleave ME; Collins C; Dong X
    Eur Urol; 2019 Aug; 76(2):157-166. PubMed ID: 30910347
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.